Abstract
Oncogenic rearrangements of the NTRK1 gene (also designated TRKA), encoding one of the receptors for the nerve growth factor, are frequently detected in thyroid carcinomas. Such rearrangements fuse the NTRK1 tyrosine kinase domain to 5'-end sequences belonging to different genes. In previously reported studies we have demonstrated that NTRK1 oncogenic activation involves two genes, TPM3 and TPR, both localized similarly to the receptor tyrosine kinase, on the q arm of chromosome 1. Here we report the characterization of a novel NTRK1-derived thyroid oncogene, named TRK-T3. A cDNA clone, capable of transforming activity, was isolated from a transformant cell line. Sequence analysis revealed that TRK-T3 contains 1,412 nucleotides of NTRK1 preceded by 598 nucleotides belonging to a novel gene that we have named TFG (TRK-fused gene). The TRK-T3 amino acid sequence displays, within the TFG region, a coiled-coil motif that could endow the oncoprotein with the capability to form complexes. The TRK-T3 oncogene encodes a 68-kDa cytoplasmic protein reacting with NTRK1-specific antibodies. By sedimentation gradient experiments the TRK-T3 oncoprotein was shown to form, in vivo, multimeric complexes, most likely trimers or tetramers. The TFG gene is ubiquitously expressed and is located on chromosome 3. The breakpoint producing the TRK-T3 oncogene occurs within exons of both the TFG gene and the NTRK1 gene and produces a chimeric exon that undergoes alternative splicing. Molecular analysis of the NTRK1 rearranged fragments indicated that the chromosomal rearrangement is reciprocal and balanced and involves loss of a few nucleotides of germ line sequences.
Full Text
The Full Text of this article is available as a PDF (732.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barbacid M., Lamballe F., Pulido D., Klein R. The trk family of tyrosine protein kinase receptors. Biochim Biophys Acta. 1991 Dec 10;1072(2-3):115–127. doi: 10.1016/0304-419x(91)90010-i. [DOI] [PubMed] [Google Scholar]
- Boehm T., Mengle-Gaw L., Kees U. R., Spurr N., Lavenir I., Forster A., Rabbitts T. H. Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours. EMBO J. 1989 Sep;8(9):2621–2631. doi: 10.1002/j.1460-2075.1989.tb08402.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bongarzone I., Monzini N., Borrello M. G., Carcano C., Ferraresi G., Arighi E., Mondellini P., Della Porta G., Pierotti M. A. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Mol Cell Biol. 1993 Jan;13(1):358–366. doi: 10.1128/mcb.13.1.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bongarzone I., Pierotti M. A., Monzini N., Mondellini P., Manenti G., Donghi R., Pilotti S., Grieco M., Santoro M., Fusco A. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene. 1989 Dec;4(12):1457–1462. [PubMed] [Google Scholar]
- Borrello M. G., Pelicci G., Arighi E., De Filippis L., Greco A., Bongarzone I., Rizzetti M., Pelicci P. G., Pierotti M. A. The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins. Oncogene. 1994 Jun;9(6):1661–1668. [PubMed] [Google Scholar]
- Butti M. G., Bongarzone I., Ferraresi G., Mondellini P., Borrello M. G., Pierotti M. A. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas. Genomics. 1995 Jul 1;28(1):15–24. doi: 10.1006/geno.1995.1100. [DOI] [PubMed] [Google Scholar]
- Byrd D. A., Sweet D. J., Panté N., Konstantinov K. N., Guan T., Saphire A. C., Mitchell P. J., Cooper C. S., Aebi U., Gerace L. Tpr, a large coiled coil protein whose amino terminus is involved in activation of oncogenic kinases, is localized to the cytoplasmic surface of the nuclear pore complex. J Cell Biol. 1994 Dec;127(6 Pt 1):1515–1526. doi: 10.1083/jcb.127.6.1515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ellenberger T. E., Brandl C. J., Struhl K., Harrison S. C. The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted alpha helices: crystal structure of the protein-DNA complex. Cell. 1992 Dec 24;71(7):1223–1237. doi: 10.1016/s0092-8674(05)80070-4. [DOI] [PubMed] [Google Scholar]
- Ferré-D'Amaré A. R., Prendergast G. C., Ziff E. B., Burley S. K. Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature. 1993 May 6;363(6424):38–45. doi: 10.1038/363038a0. [DOI] [PubMed] [Google Scholar]
- Greco A., Mariani C., Miranda C., Pagliardini S., Pierotti M. A. Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes. Genomics. 1993 Nov;18(2):397–400. doi: 10.1006/geno.1993.1482. [DOI] [PubMed] [Google Scholar]
- Greco A., Orlandi R., Mariani C., Miranda C., Borrello M. G., Cattaneo A., Pagliardini S., Pierotti M. A. Expression of TRK-T1 oncogene induces differentiation of PC12 cells. Cell Growth Differ. 1993 Jul;4(7):539–546. [PubMed] [Google Scholar]
- Greco A., Pierotti M. A., Bongarzone I., Pagliardini S., Lanzi C., Della Porta G. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene. 1992 Feb;7(2):237–242. [PubMed] [Google Scholar]
- Harbury P. B., Zhang T., Kim P. S., Alber T. A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science. 1993 Nov 26;262(5138):1401–1407. doi: 10.1126/science.8248779. [DOI] [PubMed] [Google Scholar]
- Jego N., Thomas G., Hamelin R. Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. Oncogene. 1993 Jan;8(1):209–213. [PubMed] [Google Scholar]
- Kaplan D. R., Hempstead B. L., Martin-Zanca D., Chao M. V., Parada L. F. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science. 1991 Apr 26;252(5005):554–558. doi: 10.1126/science.1850549. [DOI] [PubMed] [Google Scholar]
- Klein R., Jing S. Q., Nanduri V., O'Rourke E., Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell. 1991 Apr 5;65(1):189–197. doi: 10.1016/0092-8674(91)90419-y. [DOI] [PubMed] [Google Scholar]
- Knapp S., Delle Karth G., Friedl J., Purtscher B., Mitterbauer G., Domer P. H., Jaeger U. Guanine-rich (GGNNGG) elements at chromosomal breakpoints interact with a loop-forming, single-stranded DNA-binding protein. Oncogene. 1994 May;9(5):1501–1505. [PubMed] [Google Scholar]
- Kozak M. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987 Oct 26;15(20):8125–8148. doi: 10.1093/nar/15.20.8125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krowczynska A. M., Rudders R. A., Krontiris T. G. The human minisatellite consensus at breakpoints of oncogene translocations. Nucleic Acids Res. 1990 Mar 11;18(5):1121–1127. doi: 10.1093/nar/18.5.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin-Zanca D., Hughes S. H., Barbacid M. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. 1986 Feb 27-Mar 5Nature. 319(6056):743–748. doi: 10.1038/319743a0. [DOI] [PubMed] [Google Scholar]
- Martin-Zanca D., Oskam R., Mitra G., Copeland T., Barbacid M. Molecular and biochemical characterization of the human trk proto-oncogene. Mol Cell Biol. 1989 Jan;9(1):24–33. doi: 10.1128/mcb.9.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Minoletti F., Butti M. G., Coronelli S., Miozzo M., Sozzi G., Pilotti S., Tunnacliffe A., Pierotti M. A., Bongarzone I. The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2. Genes Chromosomes Cancer. 1994 Sep;11(1):51–57. doi: 10.1002/gcc.2870110108. [DOI] [PubMed] [Google Scholar]
- Miozzo M., Pierotti M. A., Sozzi G., Radice P., Bongarzone I., Spurr N. K., Della Porta G. Human TRK proto-oncogene maps to chromosome 1q32-q41. Oncogene. 1990 Sep;5(9):1411–1414. [PubMed] [Google Scholar]
- Mitra G., Martin-Zanca D., Barbacid M. Identification and biochemical characterization of p70TRK, product of the human TRK oncogene. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6707–6711. doi: 10.1073/pnas.84.19.6707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morris C. M., Hao Q. L., Heisterkamp N., Fitzgerald P. H., Groffen J. Localization of the TRK proto-oncogene to human chromosome bands 1q23-1q24. Oncogene. 1991 Jun;6(6):1093–1095. [PubMed] [Google Scholar]
- Park M., Dean M., Cooper C. S., Schmidt M., O'Brien S. J., Blair D. G., Vande Woude G. F. Mechanism of met oncogene activation. Cell. 1986 Jun 20;45(6):895–904. doi: 10.1016/0092-8674(86)90564-7. [DOI] [PubMed] [Google Scholar]
- Pfeiffer P., Thode S., Hancke J., Vielmetter W. Mechanisms of overlap formation in nonhomologous DNA end joining. Mol Cell Biol. 1994 Feb;14(2):888–895. doi: 10.1128/mcb.14.2.888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pierotti M. A., Santoro M., Jenkins R. B., Sozzi G., Bongarzone I., Grieco M., Monzini N., Miozzo M., Herrmann M. A., Fusco A. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1616–1620. doi: 10.1073/pnas.89.5.1616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rabbitts T. H. Chromosomal translocations in human cancer. Nature. 1994 Nov 10;372(6502):143–149. doi: 10.1038/372143a0. [DOI] [PubMed] [Google Scholar]
- Radice P., Sozzi G., Miozzo M., De Benedetti V., Cariani T., Bongarzone I., Spurr N. K., Pierotti M. A., Della Porta G. The human tropomyosin gene involved in the generation of the TRK oncogene maps to chromosome 1q31. Oncogene. 1991 Nov;6(11):2145–2148. [PubMed] [Google Scholar]
- Richardson J. S., Richardson D. C. Amino acid preferences for specific locations at the ends of alpha helices. Science. 1988 Jun 17;240(4859):1648–1652. doi: 10.1126/science.3381086. [DOI] [PubMed] [Google Scholar]
- Rodrigues G. A., Park M. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol Cell Biol. 1993 Nov;13(11):6711–6722. doi: 10.1128/mcb.13.11.6711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Santoro M., Rosati R., Grieco M., Berlingieri M. T., D'Amato G. L., de Franciscis V., Fusco A. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene. 1990 Oct;5(10):1595–1598. [PubMed] [Google Scholar]
- Sozzi G., Bongarzone I., Miozzo M., Cariani C. T., Mondellini P., Calderone C., Pilotti S., Pierotti M. A., Della Porta G. Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas. Genes Chromosomes Cancer. 1992 Oct;5(3):212–218. doi: 10.1002/gcc.2870050307. [DOI] [PubMed] [Google Scholar]
- Szentirmay Z., Ishizaka Y., Ohgaki H., Tahira T., Nagao M., Esumi H. Demonstration by in situ hybridization of ret proto-oncogene mRNA in developing placenta during mid-term of rat gestation. Oncogene. 1990 May;5(5):701–705. [PubMed] [Google Scholar]
- Wahls W. P., Wallace L. J., Moore P. D. The Z-DNA motif d(TG)30 promotes reception of information during gene conversion events while stimulating homologous recombination in human cells in culture. Mol Cell Biol. 1990 Feb;10(2):785–793. doi: 10.1128/mcb.10.2.785. [DOI] [PMC free article] [PubMed] [Google Scholar]